Package 10135-798-41

Brand: oxcarbazepine

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 10135-798-41
Digits Only 1013579841
Product NDC 10135-798
Description

250 mL in 1 BOTTLE, GLASS (10135-798-41)

Marketing

Marketing Status
Marketed Since 2025-05-01
Brand oxcarbazepine
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "38688247-8bdb-ee98-e063-6294a90a8ef6", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0310135798414"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["d3684d55-0564-4849-bdf6-b91f22a3e28c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Marlex Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 BOTTLE, GLASS (10135-798-41)", "package_ndc": "10135-798-41", "marketing_start_date": "20250501"}], "brand_name": "Oxcarbazepine", "product_id": "10135-798_38688247-8bdb-ee98-e063-6294a90a8ef6", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "10135-798", "generic_name": "Oxcarbazepine", "labeler_name": "Marlex Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/5mL"}], "application_number": "ANDA217782", "marketing_category": "ANDA", "marketing_start_date": "20250501", "listing_expiration_date": "20261231"}